Medrogestone produced in accordance with the process of this invention exhibits {HEAD ~ an HPLC strength} in {TAIL ~ the order} of 99.2% with total impurities at about 0.08% , thereby providing a very pure therapeutic agent 
in
Medrogestone produced in accordance with the process of this invention exhibits { HEAD ~ an HPLC strength } in { TAIL ~ the order } of 99.2 % with total impurities at about 0.08 % , thereby providing a very pure therapeutic agent
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH